(Q65002032)

3 July 2019

reason for preferred rank

editorial

0 references

title

Active Cancer Therapy Combining 13-cis-Retinoic Acid With Interferon- (English)

1 reference

https://api.crossref.org/works/10.1093/JNCI/84.4.218

11 November 2022

Active cancer therapy combining 13-cis-retinoic acid with interferon-alpha (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1734081

11 November 2022

1 reference

https://api.crossref.org/works/10.1093/JNCI/84.4.218

11 November 2022

author name string

E. Dmitrovsky

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1734081

11 November 2022

G. J. Bosl

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1734081

11 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

3 July 2019

19 February 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1734081

full work available at URL

11 November 2022

http://academic.oup.com/jnci/article-pdf/84/4/218/7805632/84-4-218.pdf

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1093/JNCI/84.4.218

Journal of the National Cancer Institute

11 November 2022

published in

1 reference

3 July 2019

volume

84

1 reference

3 July 2019

issue

4

1 reference

3 July 2019

page(s)

218-219

1 reference

3 July 2019

Identifiers

DOI

1 reference

3 July 2019

1 reference

3 July 2019